Cord Blood Stem Cells Market

Cord Blood Stem Cells Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

145

Base Year:

2022

Aug - 2023

Format:

Report Code:

VMR-VMR-2021-0195

Segments Covered

By Type Allogeneic Stem Cell , Autologous Stem Cell
By Application Autoimmune Diseases , Immunodeficiencies , Malignancies , Caners , Solid Tumors
By End User Therapeutics Service Companies, Private and Government Research Institutes, Academic Institutes, Research-Based Pharmaceutical Companies, Public and Private Cord Blood Banks, Others
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2022
Forecast Years:	2023 - 2030
Historical Years:	2017 - 2021
Revenue 2022:	USD 1615 Million
Revenue 2030:	USD 2318.31 Million
Revenue CAGR (2023 - 2030):	5.3%
Fastest Growing Region (2023 - 2030)	Asia Pacific
Largest Region (2022):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Cord Blood Stem Cells Market - Segment Analysis
1. Overview
2. Global Cord Blood Stem Cells Market, 2016 - 2028 (USD Million)
3. Global Cord Blood Stem Cells Market - by Type
  1. By Allogeneic Stem Cell
  2. By Autologous Stem Cell
4. Global Cord Blood Stem Cells Market - by Application
  1. By Autoimmune Diseases
  2. By Immunodeficiencies
  3. By Malignancies
  4. By Caners
  5. By Solid Tumors
5. Global Cord Blood Stem Cells Market - by End User
  1. By Therapeutics Service Companies
  2. By Private and Government Research Institutes
  3. By Academic Institutes
  4. By Research-Based Pharmaceutical Companies
  5. By Public and Private Cord Blood Banks
  6. By Others
6. Global Cord Blood Stem Cells Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
7. Market comparative analysis
North America Cord Blood Stem Cells Market - Segment Analysis
1. Overview
2. North America Cord Blood Stem Cells Market, 2016 - 2028 (USD Million)
3. North America Cord Blood Stem Cells Market, by Type
  1. By Allogeneic Stem Cell
  2. By Autologous Stem Cell
4. North America Cord Blood Stem Cells Market, by Application
  1. By Autoimmune Diseases
  2. By Immunodeficiencies
  3. By Malignancies
  4. By Caners
  5. By Solid Tumors
5. North America Cord Blood Stem Cells Market, by End User
  1. By Therapeutics Service Companies
  2. By Private and Government Research Institutes
  3. By Academic Institutes
  4. By Research-Based Pharmaceutical Companies
  5. By Public and Private Cord Blood Banks
  6. By Others
6. North America Cord Blood Stem Cells Market, by Country
  1. U.S.
    1. U.S. Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. U.S. Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. U.S. Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
  2. Canada
    1. Canada Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. Canada Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. Canada Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
  3. Mexico
    1. Mexico Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. Mexico Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. Mexico Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
Europe Cord Blood Stem Cells Market - Segment Analysis
1. Overview
2. Europe Cord Blood Stem Cells Market, 2016 - 2028 (USD Million)
3. Europe Cord Blood Stem Cells Market, by Type
  1. By Allogeneic Stem Cell
  2. By Autologous Stem Cell
4. Europe Cord Blood Stem Cells Market, by Application
  1. By Autoimmune Diseases
  2. By Immunodeficiencies
  3. By Malignancies
  4. By Caners
  5. By Solid Tumors
5. Europe Cord Blood Stem Cells Market, by End User
  1. By Therapeutics Service Companies
  2. By Private and Government Research Institutes
  3. By Academic Institutes
  4. By Research-Based Pharmaceutical Companies
  5. By Public and Private Cord Blood Banks
  6. By Others
6. Europe Cord Blood Stem Cells Market, by Country
  1. Germany
    1. Germany Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. Germany Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. Germany Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
  2. UK
    1. UK Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. UK Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. UK Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
  3. France
    1. France Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. France Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. France Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
  4. Spain
    1. Spain Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. Spain Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. Spain Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
  5. Italy
    1. Italy Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. Italy Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. Italy Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
  6. BENELUX
    1. BENELUX Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. BENELUX Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. BENELUX Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
  7. Rest of Europe
    1. Rest Of Europe Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. Rest Of Europe Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. Rest Of Europe Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
Asia Pacific Cord Blood Stem Cells Market - Segment Analysis
1. Overview
2. Asia Pacific Cord Blood Stem Cells Market, 2016 - 2028 (USD Million)
3. Asia Pacific Cord Blood Stem Cells Market, by Type
  1. By Allogeneic Stem Cell
  2. By Autologous Stem Cell
4. Asia Pacific Cord Blood Stem Cells Market, by Application
  1. By Autoimmune Diseases
  2. By Immunodeficiencies
  3. By Malignancies
  4. By Caners
  5. By Solid Tumors
5. Asia Pacific Cord Blood Stem Cells Market, by End User
  1. By Therapeutics Service Companies
  2. By Private and Government Research Institutes
  3. By Academic Institutes
  4. By Research-Based Pharmaceutical Companies
  5. By Public and Private Cord Blood Banks
  6. By Others
6. Asia Pacific Cord Blood Stem Cells Market, by Country
  1. China
    1. China Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. China Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. China Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
  2. Japan
    1. Japan Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. Japan Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. Japan Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
  3. India
    1. India Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. India Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. India Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
  4. South Korea
    1. South Korea Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. South Korea Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. South Korea Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
  5. South East Asia
    1. South East Asia Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. South East Asia Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. South East Asia Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. Rest of Asia Pacific Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. Rest of Asia Pacific Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
Latin America Cord Blood Stem Cells Market - Segment Analysis
1. Overview
2. Latin America Cord Blood Stem Cells Market, 2016 - 2028 (USD Million)
3. Latin America Cord Blood Stem Cells Market, by Type
  1. By Allogeneic Stem Cell
  2. By Autologous Stem Cell
4. Latin America Cord Blood Stem Cells Market, by Application
  1. By Autoimmune Diseases
  2. By Immunodeficiencies
  3. By Malignancies
  4. By Caners
  5. By Solid Tumors
5. Latin America Cord Blood Stem Cells Market, by End User
  1. By Therapeutics Service Companies
  2. By Private and Government Research Institutes
  3. By Academic Institutes
  4. By Research-Based Pharmaceutical Companies
  5. By Public and Private Cord Blood Banks
  6. By Others
6. Latin America Cord Blood Stem Cells Market, by Country
  1. Brazil
    1. Brazil Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. Brazil Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. Brazil Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
  2. Argentina
    1. Argentina Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. Argentina Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. Argentina Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
  3. Rest of Latin America
    1. Rest of Latin America Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. Rest of Latin America Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. Rest of Latin America Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
Middle East & Africa Cord Blood Stem Cells Market - Segment Analysis
1. Overview
2. Middle East & Africa Cord Blood Stem Cells Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Cord Blood Stem Cells Market, by Type
  1. By Allogeneic Stem Cell
  2. By Autologous Stem Cell
4. Middle East & Africa Cord Blood Stem Cells Market, by Application
  1. By Autoimmune Diseases
  2. By Immunodeficiencies
  3. By Malignancies
  4. By Caners
  5. By Solid Tumors
5. Middle East & Africa Cord Blood Stem Cells Market, by End User
  1. By Therapeutics Service Companies
  2. By Private and Government Research Institutes
  3. By Academic Institutes
  4. By Research-Based Pharmaceutical Companies
  5. By Public and Private Cord Blood Banks
  6. By Others
6. Middle East & Africa Cord Blood Stem Cells Market, by Country
  1. GCC Countries
    1. GCC Countries Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. GCC Countries Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. GCC Countries Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
  2. South Africa
    1. South Africa Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. South Africa Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. South Africa Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Cord Blood Stem Cells Market, By Type
      1. By Allogeneic Stem Cell
      2. By Autologous Stem Cell
    2. Rest of Middle East & Africa Cord Blood Stem Cells Market, By Application
      1. By Autoimmune Diseases
      2. By Immunodeficiencies
      3. By Malignancies
      4. By Caners
      5. By Solid Tumors
    3. Rest of Middle East & Africa Cord Blood Stem Cells Market, By End User
      1. By Therapeutics Service Companies
      2. By Private and Government Research Institutes
      3. By Academic Institutes
      4. By Research-Based Pharmaceutical Companies
      5. By Public and Private Cord Blood Banks
      6. By Others
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. BioCell Pty. Ltd.
2. Kaneka Corporation
3. DomaniCell LLC
4. Future Health Technologies
5. Eticur
6. Advanced Cell Technology Inc.
7. Banco De Celulas Madre
8. J.P. McCarthy Cord Stem Cell Bank
9. CyGenics Ltd
10. AlphaCord.
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

FAQ

Frequently Asked Question

What is the global demand for Cord Blood Stem Cells in terms of revenue?

The global Cord Blood Stem Cells valued at USD 1615 Million in 2022 and is expected to reach USD 2318.31 Million in 2030 growing at a CAGR of 5.3%.

Which are the prominent players in the market?

The prominent players in the market are BioCell Pty. Ltd., Kaneka Corporation, DomaniCell LLC, Future Health Technologies, Eticur, Advanced Cell Technology Inc., Banco De Celulas Madre, J.P. McCarthy Cord Stem Cell Bank, CyGenics Ltd, AlphaCord..

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 5.3% between 2023 and 2030.

What are the driving factors fueling the growth of the market.

The driving factors of the Cord Blood Stem Cells include
- Increasing awareness about the therapeutic potential

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Cord Blood Stem Cells in 2022.

Cord Blood Stem Cells Market

Cord Blood Stem Cells Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Cord Blood Stem Cells in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Vantage Market Research

Products & Services

Media

Contact Us

Cord Blood Stem Cells Market

Cord Blood Stem Cells Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Cord Blood Stem Cells in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Cord Blood Stem Cells Market

Vantage Point Interactive Dashboard